Clinical Trials on Leukemia, Myeloid, Accelerated Phase in France
Total 537 results
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Incyte Biosciences International SàrlRecruitingLymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid LeukemiaSpain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
-
Children's Oncology GroupPfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...Active, not recruitingAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CMLUnited States
-
Bristol-Myers SquibbCompletedLeukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myeloid Leukemia, Chronic, Accelerated PhaseAustralia, Canada, France, Germany, Italy, Korea, Republic of, Taiwan, Thailand, United States, Spain, Austria, Denmark, Belgium, Sweden, Switzerland, Netherlands, Peru, South Africa, Philippines, Singapore, Russian Federation, Br... and more
-
Versailles HospitalRecruitingCHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE | CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISISFrance
-
Hybrigenics CorporationUnknown
-
Hospices Civils de LyonUnknown
-
University of California, IrvineRecruitingChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous LeukemiaUnited States
-
Bristol-Myers SquibbCompletedChronic Phase Chronic Myeloid LeukemiaFrance, Italy, United States, Korea, Republic of, Germany
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
Bristol-Myers SquibbPPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON... and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaUnited States, Canada, France, Germany, Italy, Spain
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
-
Hospices Civils de LyonCompletedChronic Myelogenous LeukemiaFrance
-
Centre Hospitalier Universitaire de NīmesWithdrawnLeukemia, Myeloid, Chronic-PhaseFrance
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
Centre Hospitalier Henri Duffaut - AvignonRecruitingChronic Myelogenous Leukemia - Chronic PhaseFrance
-
Institut BergoniéNovartisTerminatedLeukemia, Myeloid, Chronic-PhaseFrance
-
Hospices Civils de LyonCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada, Australia, Puerto Rico
-
Versailles HospitalCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruitingAcute Myeloid LeukaemiaUnited States, Australia, France, Spain
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
Versailles HospitalRecruitingLeukemia, Myeloid, Chronic-PhaseFrance
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
University Hospital, Clermont-FerrandCentre Leon Berard; Versailles Hospital; University Hospital, Grenoble; Institut... and other collaboratorsRecruitingChronic Myeloid Leukemia (CML) | Chronic PhaseFrance
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
SanofiTerminated
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
University of BirminghamAssistance Publique - Hôpitaux de Paris; Pfizer; Cancer Research UK; National Cancer...RecruitingAcute Myeloid LeukaemiaFrance, Switzerland, United Kingdom, New Zealand, Australia, Ireland
-
Association for Training, Education, and Research...CompletedRefractory Acute Myeloid LeukemiaFrance
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMinimal Residual Disease | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Hospices Civils de LyonRecruiting
-
Assistance Publique Hopitaux De MarseilleUnknownAcute Myeloid LeukemiaFrance
-
Institut Paoli-CalmettesCancer Research Center of MarseilleUnknown
-
French Innovative Leukemia OrganisationCelgene CorporationCompletedAcute Myeloid LeukemiaFrance
-
French Innovative Leukemia OrganisationGenzyme, a Sanofi Company; Acute Leukemia French AssociationTerminatedAcute Myeloid LeukemiaFrance
-
Assistance Publique - Hôpitaux de ParisFrench Innovative Leukemia Organisation; Acute Leukemia French AssociationCompleted
-
Nantes University HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisChiron CorporationUnknown
-
French Innovative Leukemia OrganisationCompleted
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Gustave... and other collaboratorsActive, not recruiting
-
University Hospital, BordeauxCompletedAcute Myeloid LeukemiaFrance
-
University Hospital, ToulouseCompletedAcute Myeloid LeukemiaFrance
-
French Innovative Leukemia OrganisationNovartis; Schering SACompletedGOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the ElderlyAcute Myeloid LeukemiaFrance
-
Institut Paoli-CalmettesINATHERYSRecruitingAcute Lymphoblastic Leukemia, in Relapse | Acute Myeloid Leukemia, in Relapse | Mixed Phenotype Acute Leukemia | Acute Lymphoblastic Leukemia Recurrent | Acute Myeloid Leukaemia RecurrentFrance
-
Centre Leon BerardNETRIS PharmaRecruitingAcute Myeloid Leukemia RefractoryFrance